U.S. overdose deaths involving psychostimulants other than cocaine, largely methamphetamine, increased 180% among adults under age 65 between 2015 and 2019, to 15,489, according to a study by the National Institute on Drug Abuse published this week in JAMA Psychiatry. The number of people reporting methamphetamine use increased 43% over the period, suggesting that increases in methamphetamine use disorder, frequent use and use of other drugs at the same time may be contributing to the rise in deaths, the authors said.

“What makes these data even more devastating is that currently, there are no approved medications to treat methamphetamine use disorder,” said Emily Einstein, chief of NIDA’s Science Policy Branch and a co-author of the study. 
 

Related News Articles

Headline
Nearly three-fourths of the 2.4 million U.S. adults who reported using buprenorphine in 2019 did not misuse the medication in the past 12 months, according to…
Headline
The Brigham Comprehensive Opioid Response and Education program and McLean Hospital of Belmont, Mass., on Sept. 21 at 12 p.m. ET will host a town hall virtual…
Headline
The Centers for Medicare & Medicaid Services today awarded 20 states American Rescue Plan Act grants to develop and implement mobile crisis…
Headline
The Substance Abuse and Mental Health Services Administration this week awarded $123 million in grants to help health care providers and communities…
Headline
Nearly two-thirds of U.S. adults with disabilities surveyed during February and March reported adverse mental health symptoms or substance use early this year…
Headline
The Substance Abuse and Mental Health Services Administration Friday distributed about $850,000 each to health departments in 12 states and Puerto Rico to…